维普期刊资源整合服务平台（V6.5）

33篇 您的检索式：作者名="Muggia M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Paelitaxel-Induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration : Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment 显示文摘	SYMMANS W F VOLM M D SHAPIRO R L PERKINS A B KIM A Y DEMARIA S YEE H T MCMULLEN H ORATZ R KLEIN P FORMENTI S C MUGGIA F	2000	Clin Cancer Res2000，6，12：	1
2	Complement activation by Ctemophor EL as a possible contributor to hypersensitivity to Paclilaxel:an in vitro study显示文摘	SZEBENI J MUGGIA F M AI VING C R	1998	J Natl Cancer Inst1998，90，4：	1
3	Phase Ⅱ study of liposomal doxorubicin in refractory ovarian cancer: antitu- mor activity and toxicity modification by liposomal encapsulation 显示文摘	MUGGIA F M HAINSWORTH J D JEFFERS S	1997	J Clin Oncol1997，15，3：	1
4	The cancer therapy evaluation progranm of the natinal institute显示文摘	Muggia F M	1981	Semi Oncol1981，8，：	1
5	5-Azacytidine(NSC 102816): a new anticancer drug with effectiveness in acute myelogenous leukemia 显示文摘	Von Hoff DD Slavik M Muggia FM	1976	Ann Intern Med1976，85，：	1
6	Camptothecins:a review of their development and schedules of administration显示文摘	OLeary J Muggia F M		0，，：	1
7	Phase I clinical trial of weekly and daily treatment with camptothecin ( NSC-100880 ) : correlation with preclinical studies 显示文摘	MUGGIA F M CREAVEN P J HANSEN H H	1972	Cancer Chemother Rep1972，56，：	1
8	Treatment of breast cancer with medroxyprogesterone acetate 显示文摘	Muggia FM Cassileth PA Ochoa M	1968	Ann Intern Med1968，68，2：	1
9	A phase II study of cispla- tin and vinorelbine in patients with metastatic breast cancer 显示文摘	Mustacchi G Muggia M Milani S	2002	Ann Oncol2002，13，11：	1
10	Camptothecins: a review oftheir development and schedules of administration 显示文摘	LEARY J O MUGGIA F M	1998	Eur J Cancer1998，34，10：	1
11	Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study显示文摘	Szebeni J Muggia F M Alving C R	1998	J Natl Cancer lnst1998，90，4：	1
12	Phase Ⅲrandomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage Ⅲ or Ⅳovarian cancer:a Gynecologic Oncology Group study显示文摘	Muggia F M Braly P S Brady M F	2000	J Clin Oncol2000，18，1：	1
13	Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting显示文摘	MUGGIA F M LOS G	1993	Stem Cells1993，11，：	1
14	A phase Ⅱ study of cisplatin and vinorelbine in patients with metastatic breast cancer显示文摘	Muggia M Milani S	2002	Ann Oncol2002，13，11：	1
15	Phase Ⅲ Randomized study of cisplatin vs paclitaxel vs cisplatin and paclitaxel in patients with suboptimal stage Ⅲ or Ⅳ ovarian cancer:a gynecologic oncology group study显示文摘	Muggia F M Braly P S Brady M F	2000	J Clin Oncol2000，18，1：	1
16	Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials显示文摘	ALBERTS D S MUGGIA F M CARMICHAEL J	2004	Semin Oncol2004，31，613：	1
17	Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers显示文摘	Muggia F M	2004	Semin Oncol2004，31，614：	1
18	Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix:a Gynecologic Oncology Group study显示文摘	Muggia FM Blessing JA Method M	2004	Gynecol Oncol2004，92，2：	1
19	Alphas Ⅱ study of cisplatin and vinreebine in patients with metastasis in breast cancer 显示文摘	Mustacchi G Muggia M Milani S	2003	Ann Oneol2003，13，11：	1
20	A phase Ⅱ study of cisplatin and vinorelbine in patients with metastatic breast cancer显示文摘	Mustacchi G Muggia M Milani S	2002	Ann Oncol2002，13，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示